Smart dosing aims to outsmart superbugs in the elderly
NCT ID NCT07127185
Summary
This study aims to create a personalized dosing system for a powerful antibiotic called ceftobiprole in patients aged 60 and older. It will enroll 150 older patients to measure drug levels in their blood and adjust their doses in real-time. The goal is to find the perfect dose for each person to fight serious infections effectively while minimizing the risk of side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEFTOBIPROLE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.